DuoResp Spiromax यूरोपीय संघ - क्रोएशियाई - EMA (European Medicines Agency)

duoresp spiromax

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - lijekovi za opstruktivne plućne bolesti dišnih putova, - asthma duoresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdduoresp spiromax is indicated in adults, aged 18 years and older for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).

Bupensanduo 2 mg/0,5 mg sublingvalne tablete क्रोएशिया - क्रोएशियाई - HALMED (Agencija za lijekove i medicinske proizvode)

bupensanduo 2 mg/0,5 mg sublingvalne tablete

g.l. pharma gmbh, schlossplatz 1, lannach, austrija - buprenorfinklorid naloksonklorid dihidrat - sublingvalna tableta - 2 mg + 0,5 mg - urbroj: svaka sublingvalna tableta sadrži 2 mg buprenorfina (u obliku klorida) i 0,5 mg naloksona (u obliku klorid dihidrata).

Bupensanduo 4 mg/1 mg sublingvalne tablete क्रोएशिया - क्रोएशियाई - HALMED (Agencija za lijekove i medicinske proizvode)

bupensanduo 4 mg/1 mg sublingvalne tablete

g.l. pharma gmbh, schlossplatz 1, lannach, austrija - buprenorfinklorid naloksonklorid dihidrat - sublingvalna tableta - 4 mg + 1 mg - urbroj: svaka sublingvalna tableta sadrži 4 mg buprenorfina (u obliku klorida) i 1 mg naloksona (u obliku klorid dihidrata).

Bupensanduo 8 mg/2 mg sublingvalne tablete क्रोएशिया - क्रोएशियाई - HALMED (Agencija za lijekove i medicinske proizvode)

bupensanduo 8 mg/2 mg sublingvalne tablete

g.l. pharma gmbh, schlossplatz 1, lannach, austrija - buprenorfinklorid naloksonklorid dihidrat - sublingvalna tableta - 8 mg + 2 mg - urbroj: svaka sublingvalna tableta sadrži 8 mg buprenorfina (u obliku klorida) i 2 mg naloksona (u obliku klorid dihidrata)